Raymond Jordt

Raymond Jordt has a diverse and extensive work experience. Raymond is currently working as the Chief Business Officer at Altimmune, Inc. starting from January 2023. Prior to this, they held various roles at Eli Lilly and Company. Raymond served as the Vice President, Corporate Business Development - Pain, International, Manufacturing from August 2020 to January 2023, and as the Sr. Director, Corporate Business Development from September 2016 to August 2020. Before joining Eli Lilly and Company, they worked as the Executive Director of Business Development at Achaogen from August 2015 to August 2016. Raymond also has a long history with Eli Lilly and Company, where they held several positions such as Director, Corporate Finance and Investment Banking, Director, Corporate Business Development, Manager, Corporate Business Development, Team Leader, Lilly New Ventures, Project Leader, Drug Delivery, and Research Associate. Raymond'sroles involved leading merger & acquisition deal teams, generating financial models, assessing company valuations, and leading strategic projects. Raymond also handled various types of transactions and identified and evaluated external opportunities for partnerships and venture capital investments.

Raymond Jordt earned a Bachelor of Science (BS) degree in Biomedical Engineering from Arizona State University (ASU) between 1990 and 1995. Raymond then pursued a Master of Science (MS) degree in Biomedical Engineering at The University of Memphis from 1995 to 1997. Later, they completed a Master of Business Administration (MBA) from Indiana University's Kelley School of Business from 2005 to 2007.